Avedro Eye Treatment’s Second Rejection Driven By Device, Not Drug
This article was originally published in The Gray Sheet
Executive Summary
Lukewarm support by FDA’s advisors couldn’t get Avedro’s Phoetrexa through agency on its second try, but company seems committed to a third shot at approval.